about
Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests.Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital.In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients.Comparison of DNA Microarray, Loop-Mediated Isothermal Amplification (LAMP) and Real-Time PCR with DNA Sequencing for Identification of Fusarium spp. Obtained from Patients with Hematologic Malignancies.Detection of Pneumocystis jirovecii by nested PCR in HIV-negative patients with pulmonary disease.Severe Paracoccidioidomycosis in a 14-Year-Old Boy.Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species.Influence of the Culture Medium in Dose-Response Effect of the Chlorhexidine on Streptococcus mutans Biofilms.Development of cycling probe-based real-time PCR system to detect Fusarium species and Fusarium solani species complex (FSSC).Trichosporon species infection in bone marrow transplanted patients.Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp.Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient.Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.Evaluation of antifungal combination against Cryptococcus spp.Antifungal susceptibility and pathogenic potential of environmental isolated filamentous fungi compared with colonizing agents in immunocompromised patients.Evaluation of Fusarium solani hyphae and conidia susceptibility to amphotericin B and itraconazole: study of a clinical case.Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil.Visible DNA Microarray System as an Adjunctive Molecular Test in Identification of Pathogenic Fungi Directly from a Blood Culture Bottle.Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.Airborne transmission of invasive fusariosis in patients with hematologic malignancies.Candida parapsilosis Fungemia Associated with Implantable and Semi-Implantable Central Venous Catheters and the Hands of Healthcare WorkersFirst evidence and characterization of an uncoupling protein in fungi kingdom: CpUCP of Candida parapsilosisEvaluation of the inhibitory effect of amphotericin B on the apical growth of F. solani using the BioCell-Tracer systemStandardization of hyphal growth inhibition rate as a means of evaluating Microsporum spp. in vitro susceptibility to terbinafine, griseofulvin, and ciclopiroxolamineSusceptibility testing of terbinafine alone and in combination with amphotericin B, itraconazole, or voriconazole against conidia and hyphae of dematiaceous moldsMortality related to candidemia and risk factors associated with non-Candida albicansAspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil
P50
Q34156917-2959C3C1-860B-4161-A925-C5D22A683E15Q36077230-F161CC4B-B253-4204-B280-53AD82CA9C18Q38282878-1EB8ED96-2C9F-4069-94E3-C851C379EDF1Q40113026-4819236C-DA98-46A7-9ED1-DA536289748BQ40285695-E9255CE8-45FB-42D4-AE04-C89AD485407FQ40327238-18B8FDB0-BC04-43D0-939C-2EA4080F2CDAQ40629624-779F2350-9F14-42B4-8454-68C7A65BCC41Q41613426-657E00B7-2A33-4C09-BB5A-48347C119609Q41812210-7FC97E3C-304E-4864-A558-4C3379DD3A2DQ42220530-4DE0F4E1-6874-4935-AB02-0E2DB136B679Q43597716-13F2724C-D10C-4658-A87B-28697E3FD179Q44657018-D01599DB-023A-4545-B8FB-797883238422Q44697938-74C56C1D-B5C2-410A-8C66-FD0AC0A88D5BQ46142983-B9CEBC61-6453-424E-B201-F3A1BFFAC71FQ46554956-E94BF987-84FF-44CB-9673-564AA3BFB127Q46710086-64E3D8D4-B14A-4740-8B7E-E4E4F120DCFDQ46770388-FCC84352-C99B-4FE1-B2E7-FFE8BBFFA6E0Q50917195-E8E3FF18-2E87-4041-ABC5-9EB1ABABC260Q54260402-F0BAAE08-E6A0-4118-8613-FDB66AC3A28DQ54268900-8CE2C519-EEE3-4A73-809E-C378E7F73776Q55014642-FD4313FA-06E5-42C9-A4BE-60FDD6E6D182Q63197408-11EE8ADD-B04E-463C-B48E-A4E71D890670Q73450411-9CFC281A-9700-402D-8263-C3EBC1B076D2Q80247412-FDAAF5A4-4632-4335-BC4E-C3BB475D10B3Q84193175-7E1D3F44-FFEC-48AB-BAE6-010CD198903BQ84980779-A49FB839-5A2B-43E5-8793-914F8ADE5A7BQ85895397-1BDF5980-30B1-49E9-865D-83DAD74C574BQ92216853-6648A2B8-6C12-461B-966E-5AA14ED9221D
P50
description
researcher
@en
wetenschapper
@nl
name
A Z Schreiber
@en
A Z Schreiber
@nl
type
label
A Z Schreiber
@en
A Z Schreiber
@nl
prefLabel
A Z Schreiber
@en
A Z Schreiber
@nl
P106
P31
P496
0000-0002-5095-5054